Abstract
The standard ELISA technique was improved for the detection of antigalactocerebroside antibody in biological fluid. Mouse monoclonal antigalactocerebroside antibody was used to demonstrate specificity and sensitivity of the technique. After optimization of the assay, the usefulness of this measurement for the evaluation of patients with multiple sclerosis was assessed. The presence of antigalactocerebroside antibodies in the cerebrospinal fluid of 20 patients with multiple sclerosis, 10 with other neurological diseases and 10 normal individuals was determined. All the CSF samples from normal individuals were negative. In patients with multiple sclerosis 14 of the 20 samples had elevated levels of antigalactocerebroside antibody, whereas with other neurological diseases 5 out of 10 were positive. Antigalactocerebroside levels were lower in samples from patients during an acute relapse than in those from more chronic cases. These results indicate that the presence of anti-galactocerebroside antibody in cerebrospinal fluid is not specific to MS but may reflect previous damage to myelin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- ELISA:
-
Enzyme-Linked Immunosorbent Assay
- CSF:
-
cerebrospinal fluid; galacto- or glucocerebroside, ceramide-1-0-beta-galactoside or-glucoside
References
Saida, T., Saida, K., Silberberg, D. H., and Brown, M. J. 1978. Transfer of Demyelination with Experimental Allergic Neuritis Serum by Intraneural injection. Nature 272:639–641.
McKhann, G. M. 1982. Multiple Sclerosis, Ann. Rev. Neurosci. 5:219–239.
Ruutiainen, J., Reunanen, M., and Frey, H. 1982. Galactocerebroside Antibody Level in Multiple Sclerosis. Proc. 24th Scandinavian Congress of Neurology 65:260–261.
Kasai, N., Pachner, A. R., and Yu, R. K., 1986. Anti-glycolipid Antibodies and their Immune Complex in Multiple Sclerosis. J. Neurol. Sci. 75:33–42.
Blackburn, C. C., and Schnaar, R. L. 1983. Carbohydratespecific Cell Adhesion is Mediated by Immobilized Glycolipids. J. Biol. Chem. 258:1180–1188.
Kishimoto, Y. (1978). Research Methods in Neurochemistryin N. Marks, and R. Rodnight (eds.). Plenum Press, New York, pp. 411–436.
Ranscht, B., Clapshaw, P. A., Pria, J., Noble, M., and Siefert, W. 1982. Development of Oligodendrocytes and Schwann Cells with Monoclonal Antibody Against Galactocerebroside. Proc. Nat. Acad. Sci. 79:2709–2713.
Rose, A. S. 1981. Multiple Sclerosis: An Overview, Pages 3–9,in Waxman, S. G. and Ritchie, J. M. (eds.), Demyelination Disease: Basic and Clinical Electrophysiology, Raven Press, New York.
McFarlin, D. E., and McFarland, H. F. 1982. Multiple Sclerosis, New Eng. J. Med. 307:1183–1188.
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, C. C. Johnson, K. P., Sibley, W. A., Silberberg, D. H., and Tourtellotte, W. W. 1983. New Diagnostic Criteria for Multiple Sclerosis: Guidelines for Research Protocols, Ann. Neurol. 13:227–231.
Cohen, S. R., Herndon, R. M., and McKhann, G. M. 1976. Radioimmunoassay for Myelin Basic Protein in Spinal Fluid: An Index of Active Demyelination. New Eng. J. Med. 295:1455–1457.
Warren, K. G., Catz, I. 1986. Diagnostic Value of Cerebrospinal Fluid Anti-Myelin Basic Protein in Patients with Multiple Sclerosis. Ann Neurol. 20:20–25.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ichioka, T., Uobe, Ki., Stoskopf, M. et al. Anti-galactocerebroside antibodiesin human cerebrospinal fluids determined by enzyme-linked immunosorbent assay (ELISA). Neurochem Res 13, 203–207 (1988). https://doi.org/10.1007/BF00971533
Issue Date:
DOI: https://doi.org/10.1007/BF00971533